References

1. Human Resources Director. Nearly half of Australians suffer from burnout, says new ELMO report [Internet]. Sydney: Key Media; 2022 [cited 2022 Aug 31]. Available from: https://www.hcamag.com/au/specialisation/employment-law/nearly-half-of-australians-suffer-from-burnout-says-new-elmo-report/403313

2. Guidi J, Lucente M, Sonino N, Fava GA. Allostatic load and its impact on health: a systematic review. Psychother Psychosom. 2021;90(1):11-27. DOI: 10.1159/000510696

3. Herman JP, McKlveen JM, Ghosal S, Kopp B, Wulsin A, Makinson R, et al. Regulation of the hypothalamic-pituitary-adrenocortical stress response. Compr Physiol. 2016 Mar;6(2):603-621. DOI: 10.1002/cphy.c150015

4. McEwen BS. Stress, adaptation, and disease. Allostasis and allostatic load. Ann N Y Acad Sci. 1998 May 1;840:33-44. DOI: 10.1111/j.1749-6632.1998.tb09546.x

5. Munir S, Takov V. Generalized anxiety disorder [Internet]. Treasure Island: StatPearls; 2022 [cited 2022 Aug 31]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK441870/

6. Yang L, Zhao Y, Wang Y, Liu L, Zhang X, Li B, et al. The effects of psychological stress on depression. Curr Neuropharmacol. 2015 Jul;13(4):494-504. DOI: 10.2174/1570159X1304150831150507

7. Hammen C. Stress and depression. Annu Rev Clin Psychol. 2005;1:293-319. DOI: 10.1146/annurev.clinpsy.1.102803.143938

8. Nene Y, Tadi P. Resident burnout [Internet]. Treasure Island: StatPearls; 2022 [cited 2022 Aug 31]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK553176/

9. McEwen BS, Sapolsky RM. Stress and cognitive function. Curr Opin Neurobiol. 1995 Apr;5(2):205-216. DOI: 10.1016/0959-4388(95)80028-x

10. Chao AM, Jastreboff AM, White MA, Grilo CM, Sinha R. Stress, cortisol, and other appetite-related hormones: prospective prediction of 6-month changes in food cravings and weight. Obesity (Silver Spring). 2017 Apr;25(4):713-720. DOI: 10.1002/oby.21790

11. Gouin JP, Hantsoo L, Kiecolt-Glaser JK. Immune dysregulation and chronic stress among older adults: a review. Neuroimmunomodulation. 2008;15(4-6):251-259. DOI: 10.1159/000156468

12. Godbout JP, Glaser R. Stress-induced immune dysregulation: implications for wound healing, infectious disease and cancer. J Neuroimmune Pharmacol. 2006 Dec;1(4):421-427. DOI: 10.1007/s11481-006-9036-0

13. Surkan PJ, Sakyi KS, Hu A, Olinto MT, Gonçalves H, Horta BL, et al. Impact of stressful life events on central adiposity in the Pelotas birth cohort. Rev Saude Publica. 2018;52:61. DOI: 10.11606/s1518-8787.2018052000161

14. Van Der Valk ES, Savas M, Van Rossum EFC. Stress and obesity: are there more susceptible individuals. Curr Obes Rep. 2018 Jun;7(2):193-203. DOI: 10.1007/s13679-018-0306-y

15. Epel ES, McEwen B, Seeman T, Matthews K, Castellazzo G, Brownell KD, et al. Stress and body shape: stress-induced cortisol secretion is consistently greater among women with central fat. Psychosom Med. 2000 Sep-Oct;62(5):623-632. DOI: 10.1097/00006842-200009000-00005

16. Melamed S, Shirom A, Toker S, Berliner S, Shapira I. Burnout and risk of cardiovascular disease: evidence, possible causal paths, and promising research directions. Psychol Bull. 2006 May;132(3):327-353. DOI: 10.1037/0033-2909.132.3.327

17. Kelly SJ, Ismail M. Stress and type 2 diabetes: a review of how stress contributes to the development of type 2 diabetes. Annu Rev Public Health. 2015 Mar;36:441-462. DOI: 10.1146/annurev-publhealth-031914-122921

18. Aeon B, Faber A, Panaccio A. Does time management work? A meta-analysis. PLoS One. 2021;16(1):e0245066. DOI: 10.1371/journal.pone.0245066

19. Irish LA, Kline CE, Gunn HE, Buysse DJ, Hall MH. The role of sleep hygiene in promoting public health: a review of empirical evidence. Sleep Med Rev. 2015 Aug;22:23-36. DOI: 10.1016/j.smrv.2014.10.001

20. Worthen M, Cash E. Stress management [Internet]. Treasure Island: StatPearls; 2022 [cited 2022 Sep 13]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK513300/

21. Thorne Research. Monograph. Withania somnifera. Altern Med Rev. 2004 Jun;9(2):211-214.

22. Bone K, Mills S. Principles and practice of phytotherapy: modern herbal medicine. 2nd ed. London: Churchill Livingstone; 2013. 818-825 p.

23. Al-Qarawi AA, Abdel-Rahman HA, Ali BH, El Mougy SA. Liquorice (Glycyrrhiza glabra) and the adrenal-kidney-pituitary axis in rats. Food Chem Toxicol. 2002 Oct;40(10):1525-1527. DOI: 10.1016/s0278-6915(02)00080-7

24. Armanini D, Fiore C, Mattarello MJ, Bielenberg J, Palermo M. History of the endocrine effects of licorice. Exp Clin Endocrinol Diabetes. 2002 Sep;110(6):257-261. DOI: 10.1055/s-2002-34587

25. Farese RV, Biglieri EG, Shackleton CH, Irony I, Gomez-Fontes R. Licorice-induced hypermineralocorticoidism. N Engl J Med. 1991 Oct;325(17):1223-1227. DOI: 10.1056/NEJM199110243251706

26. Mills SY, Bone K. The essential guide to herbal safety. London: Churchill Livingstone; 2005. 498-502 p.

27. Hou YC, Lin SP, Chao PDL. Liquorice reduced cyclosporine bioavailability by activating P-glycoprotein and CYP3A. Food Chem. 2012 Dec;135(4):2307-2312. DOI: 10.1016/j.foodchem.2012.07.061

28. Tu JH, He YJ, Yao C, Fan L, Zhang W, Tan ZR, et al. Effect of glycyrrhizin on the activity of CYP3A enzyme in humans. Eur J Clin Pharmacol. 2010;66(8):805-810. DOI: 10.1007/s00228-010-0814-5

29. Braun L, Cohen M, Arthur R, Fox G, McEwen B, Oates L, et al. Herbs & natural supplements, volume 2: an evidence-based guide. 4th ed. Sydney: Churchill Livingstone; 2015. 1185-1197 p.

30. Williamson E, Driver S, Baxter K. Stockley's herbal medicines interactions: a guide to the interactions of herbal medicines. London: Pharmaceutical Press; 2009. 273-274 p.

31. Sigurjónsdóttir HA, Franzson L, Manhem K, Ragnarsson J, Sigurdsson G, Wallerstedt S. Liquorice-induced rise in blood pressure: a linear dose-response relationship. J Hum Hypertens. 2001 Aug;15(8):549-552. DOI: 10.1038/sj.jhh.1001215

32. Nazari S, Rameshrad M, Hosseinzadeh H. Toxicological effects of Glycyrrhiza glabra (licorice): a review. Phytother Res. 2017 Nov;31(11):1635-1650. DOI: 10.1002/ptr.5893

33. Francini-Pesenti F, Puato M, Piccoli A, Brocadello F. Liquorice-induced hypokalaemia and water retention in the absence of hypertension. Phytother Res. 2008 Apr;22(4):563-565. DOI: 10.1002/ptr.2402

34. Bernardi M, D’Intino PE, Trevisani F, Cantelli-Forti G, Raggi MA, Turchetto E, et al. Effects of prolonged ingestion of graded doses of licorice by healthy volunteers. Life Sci. 1994;55(11):863-872. DOI: 10.1016/0024-3205(94)90042-6

35. Fugh-Berman A. Herb-drug interactions. Lancet. 2000;355(9198):134-138. DOI: 10.1016/S0140-6736(99)06457-0

36. Stargrove MB, Treasure J, McKee DL. Herb, nutrient, and drug interactions. St Louis: Mosby Elsevier; 2010. 306-337 p.

37. Natural Medicines Database [Internet]. Stockton CA: TRC Healthcare; 2022. Vitamin B6; 2022 Apr [cited 2022 Jul 11]. Available from: https://naturalmedicines.therapeuticresearch.com/databases/food,-herbs-supplements/professional.aspx?productid=934

38. Braun L, Cohen M, Arthur R, Fox G, McEwen B, Oates L, et al. Herbs & natural supplements, volume 2: an evidence-based guide. 4th ed. Sydney: Churchill Livingstone; 2015. 1087-1087 p.

39. Mulrow JP, Mulrow CD, McKenna WJ. Pyridoxine and amiodarone-induced photosensitivity. Anal Int Med. 1985;103(1):68-69. DOI: 10.7326/0003-4819-103-1-68

40. Kaufmann G. Pyridoxine against amiodarone-induced photosensitivity. Lancet. 1984;323(8367):51-52. DOI: 10.1016/S0140-6736(84)90218-6

41. Hajirahimkhan A, Simmler C, Yuan Y, Anderson JR, Chen SN, Nikolić D, et al. Evaluation of estrogenic activity of licorice species in comparison with hops used in botanicals for menopausal symptoms. PLoS One. 2013 Jul;8(7):e67947. DOI: 10.1371/journal.pone.0067947

42. Simons R, Vincken JP, Mol LAM, The SAM, Bovee TFH, Luijendijk TJC, et al. Agonistic and antagonistic estrogens in licorice root (Glycyrrhiza glabra). Anal Bioanal Chem. 2011 Jul;401:305-313. DOI: 10.1007/s00216-011-5061-9

43. Tamir S, Eizenberg M, Somjen D, Izrael S, Vaya J. Estrogen-like activity of glabrene and other constituents isolated from licorice root. J Steroid Biochem Mol Biol. 2001 Sep;78(3):291-298. DOI: 10.1016/s0960-0760(01)00093-0

44. Tamir S, Eizenberg M, Somjen D, Stern N, Shelach R, Kaye A, et al. Estrogenic and antiproliferative properties of glabridin from licorice in human breast cancer cells. Cancer Res. 2000 Oct;60(20):5704-5709.

45. Kamal HI, Patel K, Brdak A, Heffernan J, Ahmad N. Ashwagandha as a unique cause of thyrotoxicosis presenting with supraventricular tachycardia. Cureus. 2022 Mar;14(3):e23494. DOI: 10.7759/cureus.23494

46. Tandon N, Yadav SS. Safety and clinical effectiveness of Withania somnifera (Linn.) dunal root in human ailments. J Ethnopharmacol. 2020 Jun;112768. DOI: 10.1016/j.jep.2020.112768

47. Curry KM, McNeil LE, Flores A, Fuks J. Thyrotoxicosis with ashwagandha: a case report. SSRN. 2019 Dec. DOI: 10.2139/ssrn.3506409

48. Sharma AK, Basu I, Singh S. Efficacy and safety of ashwagandha root extract in subclinical hypothyroid patients: a double-blind, randomized placebo-controlled trial. J Altern Complement Med. 2018 Mar;24(3):243-248. DOI: 10.1089/acm.2017.0183

49. Van Der Hooft CS, Hoekstra A, Winter A, De Smet PAG, Ch Stricker BH. [Thyrotoxicosis following the use of ashwagandha]. Ned Tijdschr Geneeskd. 2005 Nov;149(47):2637-2638.

50. Natural Medicines Database [Internet]. Stockton CA: TRC Healthcare; 2022. Vitamin E; 2022 Jun [cited 2022 Jul 6]. Available from: https://naturalmedicines.therapeuticresearch.com/databases/food,-herbs-supplements/professional.aspx?productid=954

51. Braun L, Cohen M, Arthur R, Fox G, McEwen B, Oates L, et al. Herbs & natural supplements, volume 2: an evidence-based guide. 4th ed. Sydney: Churchill Livingstone; 2015. 1171-1172 p.

52. Stargrove MB, Treasure J, McKee DL. Herb, nutrient, and drug interactions. St Louis: Mosby Elsevier; 2010. 439-440 p.

53. Wadsworth ME, Broderick AV, Loughlin-Presnal JE, Bendezu JJ, Joos CM, Ahlkvist JA, et al. Co-activation of SAM and HPA responses to acute stress: a review of the literature and test of differential associations with preadolescents' internalizing and externalizing. Dev Psychobiol. 2019 Nov;61(7):1079-1093. DOI: 10.1002/dev.21866

54. Lowrance SA, Ionadi A, McKay E, Douglas X, Johnson JD. Sympathetic nervous system contributes to enhanced corticosterone levels following chronic stress. Psychoneuroendocrinology. 2016 Jun;68:163-170. DOI: 10.1016/j.psyneuen.2016.02.027

55. Sinha R, Talih M, Malison R, Cooney N, Anderson GM, Kreek MJ. Hypothalamic-pituitary-adrenal axis and sympatho-adreno-medullary responses during stress-induced and drug cue-induced cocaine craving states. Psychopharmacology (Berl). 2003 Oct;170(1):62-72. DOI: 10.1007/s00213-003-1525-8

56. Vrijkotte TG, Van Doornen LJ, De Geus EJ. Effects of work stress on ambulatory blood pressure, heart rate, and heart rate variability. Hypertension. 2000 Apr;35(4):880-886. DOI: 10.1161/01.hyp.35.4.880

57. Rui L. Energy metabolism in the liver. Compr Physiol. 2014 Jan;4(1):177-197. DOI: 10.1002/cphy.c130024

58. Eto K, Mazilu-Brown JK, Henderson-MacLennan N, Dipple KM, McCabe ERB. Development of catecholamine and cortisol stress responses in zebrafish. Mol Genet Metab Rep. 2014;1:373-377. DOI: 10.1016/j.ymgmr.2014.08.003

59. Conrad CD. Chronic stress-induced hippocampal vulnerability: the glucocorticoid vulnerability hypothesis. Rev Neurosci. 2008;19(6):395-411. DOI: 10.1515/revneuro.2008.19.6.395

60. Kim EJ, Pellman B, Kim JJ. Stress effects on the hippocampus: a critical review. Learn Mem. 2015 Sep;22(9):411-416. DOI: 10.1101/lm.037291.114

61. Munshi S, Loh MK, Ferrara N, DeJoseph MR, Ritger A, Padival M, et al. Repeated stress induces a pro-inflammatory state, increases amygdala neuronal and microglial activation, and causes anxiety in adult male rats. Brain Behav Immun. 2020 Feb;84:180-199. DOI: 10.1016/j.bbi.2019.11.023

62. Baxter MG, Croxson PL. Facing the role of the amygdala in emotional information processing. Proc Natl Acad Sci U S A. 2012 Dec;109(52):21180-21181. DOI: 10.1073/pnas.1219167110

63. Ressler KJ. Amygdala activity, fear, and anxiety: modulation by stress. Biol Psychiatry. 2010 Jun;67(12):1117-1119. DOI: 10.1016/j.biopsych.2010.04.027

64. Jie F, Yin G, Yang W, Yang M, Gao S, Lv J, et al. Stress in regulation of GABA amygdala system and relevance to neuropsychiatric diseases. Front Neurosci. 2018;12:562. DOI: 10.3389/fnins.2018.00562

65. Zhang X, Ge TT, Yin G, Cui R, Zhao G, Yang W. Stress-induced functional alterations in amygdala: implications for neuropsychiatric diseases. Front Neurosci. 2018;12:367. DOI: 10.3389/fnins.2018.00367

66. Mahar I, Bambico FR, Mechawar N, Nobrega JN. Stress, serotonin, and hippocampal neurogenesis in relation to depression and antidepressant effects. Neurosci Biobehav Rev. 2014 Jan;38:173-192. DOI: 10.1016/j.neubiorev.2013.11.009

67. McEwen BS, Nasca C, Gray JD. Stress effects on neuronal structure: hippocampus, amygdala, and prefrontal cortex. Neuropsychopharmacology. 2016 Jan;41(1):3-23. DOI: 10.1038/npp.2015.171

68. Popoli M, Yan Z, McEwen BS, Sanacora G. The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission. Nat Rev Neurosci. 2011 Nov;13(1):22-37. DOI: 10.1038/nrn3138

69. Gonzalez MJ, Miranda-Massari JR. Diet and stress. Psychiatr Clin North Am. 2014 Dec;37(4):579-589. DOI: 10.1016/j.psc.2014.08.004

70. McEwen BS. Protective and damaging effects of stress mediators. N Engl J Med. 1998 Jan;338(3):171-179. DOI: 10.1056/NEJM199801153380307

71. Kuhlman KR, Vargas I, Geiss EG, Lopez-Duran NL. Age of trauma onset and HPA axis dysregulation among trauma-exposed youth. J Trauma Stress. 2015 Dec;28(6):572-579. DOI: 10.1002/jts.22054

72. McGowan PO, Sasaki A, D'Alessio AC, Dymov S, Labonté B, Szyf M, et al. Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat Neurosci. 2009 Mar;12(3):342-348. DOI: 10.1038/nn.2270

73. Heim C, Newport DJ, Mletzko T, Miller AH, Nemeroff CB. The link between childhood trauma and depression: insights from HPA axis studies in humans. Psychoneuroendocrinology. 2008 Jul;33(6):693-710. DOI: 10.1016/j.psyneuen.2008.03.008

74. Juruena MF, Eror F, Cleare AJ, Young AH. The role of early life stress in HPA axis and anxiety. Adv Exp Med Biol. 2020;1191:141-153. DOI: 10.1007/978-981-32-9705-0_9

75. Faravelli C, Lo Sauro C, Lelli L, Pietrini F, Lazzeretti L, Godini L, et al. The role of life events and HPA axis in anxiety disorders: a review. Curr Pharm Des. 2012;18(35):5663-5674. DOI: 10.2174/138161212803530907

76. McEwen BS. The brain on stress: toward an integrative approach to brain, body, and behavior. Perspect Psychol Sci. 2013 Nov;8(6):673-675. DOI: 10.1177/1745691613506907

77. Rodriquez EJ, Livaudais-Toman J, Gregorich SE, Jackson JS, Nápoles AM, Pérez-Stable EJ. Relationships between allostatic load, unhealthy behaviors, and depressive disorder in U.S. adults, 2005-2012 NHANES. Prev Med. 2018 May;110:9-15. DOI: 10.1016/j.ypmed.2018.02.002

78. Tryon MS, Stanhope KL, Epel ES, Mason AE, Brown R, Medici V, et al. Excessive sugar consumption may be a difficult habit to break: a view from the brain and body. J Clin Endocrinol Metab. 2015 Jun;100(6):2239-2247. DOI: 10.1210/jc.2014-4353

79. Yau YHC, Potenza MN. Stress and eating behaviors. Minerva Endocrinol. 2013 Sep;38(3):255-267.

80. Tardy AL, Pouteau E, Marquez D, Yilmaz C, Scholey A. Vitamins and minerals for energy, fatigue and cognition: a narrative review of the biochemical and clinical evidence. Nutrients. 2020 Jan;12(1):E228. DOI: 10.3390/nu12010228

81. Lopresti AL. The effects of psychological and environmental stress on micronutrient concentrations in the body: a review of the evidence. Adv Nutr. 2020 Jan;11(1):103-112. DOI: 10.1093/advances/nmz082

82. Batalha VL, Ferreira DG, Coelho JE, Valadas JS, Gomes R, Temido-Ferreira M, et al. The caffeine-binding adenosine A2A receptor induces age-like HPA-axis dysfunction by targeting glucocorticoid receptor function. Sci Rep. 2016 Aug;6:31493. DOI: 10.1038/srep31493

83. Patz MD, Day HEW, Burow A, Campeau S. Modulation of the hypothalamo-pituitary-adrenocortical axis by caffeine. Psychoneuroendocrinology. 2006 May;31(4):493-500. DOI: 10.1016/j.psyneuen.2005.11.008

84. Maul S, Giegling I, Fabbri C, Corponi F, Serretti A, Rujescu D. Genetics of resilience: implications from genome-wide association studies and candidate genes of the stress response system in posttraumatic stress disorder and depression. Am J Med Genet B Neuropsychiatr Genet. 2020 Mar;183(2):77-94. DOI: 10.1002/ajmg.b.32763

85. Johnson EO, Calogero AE, Konstandi M, Kamilaris TC, La Vignera S, Vignera SL, et al. Effects of experimentally induced hyperthyroidism on central hypothalamic-pituitary-adrenal axis function in rats: in vitro and in situ studies. Pituitary. 2013 Jun;16(2):275-286. DOI: 10.1007/s11102-012-0417-5

86. Johnson EO, Calogero AE, Konstandi M, Kamilaris TC, La Vignera S, Chrousos GP. Effects of short- and long-duration hypothyroidism on hypothalamic-pituitary-adrenal axis function in rats: in vitro and in situ studies. Endocrine. 2012 Dec;42(3):684-693. DOI: 10.1007/s12020-012-9714-z

87. Helmreich DL, Parfitt DB, Lu XY, Akil H, Watson SJ. Relation between the hypothalamic-pituitary-thyroid (HPT) axis and the hypothalamic-pituitary-adrenal (HPA) axis during repeated stress. Neuroendocrinology. 2005;81(3):183-192. DOI: 10.1159/000087001

88. Huecker MR, Bhutta BS, Dominique E. Adrenal insufficiency [Internet]. Treasure Island: StatPearls; 2022 [cited 2022 Sep 1]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK441832/

89. Sampieri G, Namavarian A, Lee JJW, Hamour AF, Lee JM. Hypothalamic-pituitary-adrenal axis suppression and intranasal corticosteroid use: a systematic review and meta-analysis. Int Forum Allergy Rhinol. 2022 Jan;12(1):11-27. DOI: 10.1002/alr.22863

90. Zöllner EW, Lombard CJ, Galal U, Hough FS, Irusen EM, Weinberg E. Hypothalamic-pituitary-adrenal axis suppression in asthmatic school children. Pediatrics. 2012 Dec;130(6):e1512-9. DOI: 10.1542/peds.2012-1147

91. Singh N, Bhalla M, De Jager P, Gilca M. An overview on ashwagandha: a rasayana (rejuvenator) of Ayurveda. Afr J Tradit Complement Altern Med. 2011;8(5 Suppl):208-213. DOI: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3252722/

92. Thomsen M. Phytotherapy desk reference. 5th ed. 2020. 117 p.

93. Udayakumar R, Kasthurirengan S, Mariashibu TS, Rajesh M, Anbazhagan VR, Kim SC, et al. Hypoglycaemic and hypolipidaemic effects of Withania somnifera root and leaf extracts on alloxan-induced diabetic rats. Int J Mol Sci. 2009 May;10(5):2367-2382. DOI: 10.3390/ijms10052367

94. Mishra LC, Singh BB, Dagenais S. Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review. Altern Med Rev. 2000 Aug;5(4):334-346.

95. Salve J, Pate S, Debnath K, Langade D. Adaptogenic and anxiolytic effects of ashwagandha root extract in healthy adults: a double-blind, randomized, placebo-controlled clinical study. Cureus. 2019 Dec;11(12):e6466. DOI: 10.7759/cureus.6466

96. Lopresti AL, Smith SJ, Malvi H, Kodgule R. An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract: a randomized, double-blind, placebo-controlled study. Medicine (Baltimore). 2019 Sep;98(37):e17186. DOI: 10.1097/MD.0000000000017186

97. Chandrasekhar K, Kapoor J, Anishetty S. A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. Indian J Psychol Med. 2012 Jul;34(3):255-262. DOI: 10.4103/0253-7176.106022

98. Candelario M, Cuellar E, Reyes-Ruiz JM, Darabedian N, Feimeng Z, Miledi R, et al. Direct evidence for GABAergic activity of Withania somnifera on mammalian ionotropic GABAA and GABAρ receptors. J Ethnopharmacol. 2015 Aug;171:264-272. DOI: 10.1016/j.jep.2015.05.058

99. Speers AB, Cabey KA, Soumyanath A, Wright KM. Effects of Withania somnifera (ashwagandha) on stress and the stress- related neuropsychiatric disorders anxiety, depression, and insomnia. Curr Neuropharmacol. 2021;19(9):1468-1495. DOI: 10.2174/1570159X19666210712151556

100. Priyanka G, Anil Kumar B, Lakshman M, Manvitha V, Kala Kumar B. Adaptogenic and immunomodulatory activity of ashwagandha root extract: an experimental study in an equine model. Front Vet Sci. 2020;7:541112. DOI: 10.3389/fvets.2020.541112

101. Bhatnagar M, Sharma D, Salvi M. Neuroprotective effects of Withania somnifera dunal.: a possible mechanism. Neurochem Res. 2009 Nov;34(11):1975-1983. DOI: 10.1007/s11064-009-9987-7

102. Naß J, Abdelfatah S, Efferth T. Induction of stress resistance and extension of lifespan in Chaenorhabditis elegans serotonin-receptor knockout strains by withanolide A. Phytomedicine. 2021 Apr;84:153482. DOI: 10.1016/j.phymed.2021.153482

103. Mehta AK, Binkley P, Gandhi SS, Ticku MK. Pharmacological effects of Withania somnifera root extract on GABAA receptor complex. Indian J Med Res. 1991 Aug;94:312-315.

104. Bhattacharya SK, Goel RK, Kaur R, Ghosal S. Anti-stress activity of sitoindosides VII and VIII, new acylsterylglucosides from Withania somnifera. Phytother Res. 1987 Mar;1(1):32-37. DOI: 10.1002/ptr.2650010108

105. KSM66 Ashwagandha. What is KSM-66? [Internet]. Los Angeles: Ixoreal Biomed; 2022 [cited 2022 Sep 2]. Available from: https://ksm66ashwagandhaa.com/ksm-66/what-is-ksm-66/

106. Thomsen M. Phytotherapy desk reference. 5th ed. 2020. 51-52 p.

107. Panossian A, Wikman G, Kaur P, Asea A. Adaptogens exert a stress-protective effect by modulation of expression of molecular chaperones. Phytomedicine. 2009 Jun;16(6-7):617-622. DOI: 10.1016/j.phymed.2008.12.003

108. Sabbadin C, Bordin L, Donà G, Manso J, Avruscio G, Armanini D. Licorice: from pseudohyperaldosteronism to therapeutic uses. Front Endocrinol (Lausanne). 2019;10:484. DOI: 10.3389/fendo.2019.00484

109. Armanini D, Sabbadin C. Licorice and 11β-hydroxysteroid dehydrogenase. In: Huhtaniemi I, Martini L, editors. Encyclopedia of endocrine diseases. 2nd ed. Oxford: Academic Press; 2018. p. 644-651.

110. Thomsen M. Phytotherapy desk reference. 5th ed. 2020. 60-61 p.

111. Seckl JR, Walker BR. Minireview: 11beta-hydroxysteroid dehydrogenase type 1- a tissue-specific amplifier of glucocorticoid action. Endocrinology. 2001 Apr;142(4):1371-1376. DOI: 10.1210/endo.142.4.8114

112. Bone K, Mills S. Principles and practice of phytotherapy: modern herbal medicine. 2nd ed. London: Churchill Livingstone; 2013. 719-741 p.

113. Sapper H, Kang SO, Paul HH, Lohmann W. The reversibility of the vitamin C redox system: electrochemical reasons and biological aspects. Z Naturforsch C Biosci. 1982 Oct;37(10):942-946.

114. Patak P, Willenberg HS, Bornstein SR. Vitamin C is an important cofactor for both adrenal cortex and adrenal medulla. Endocr Res. 2004 Nov;30(4):871-875. DOI: 10.1081/erc-200044126

115. Padayatty SJ, Doppman JL, Chang R, Wang Y, Gill J, Papanicolaou DA, et al. Human adrenal glands secrete vitamin C in response to adrenocorticotrophic hormone. Am J Clin Nutr. 2007 Jul;86(1):145-149. DOI: 10.1093/ajcn/86.1.145

116. Kelly GS. Nutritional and botanical interventions to assist with the adaptation to stress. Altern Med Rev. 1999 Aug;4(4):249-265.

117. Moretti M, Fraga DB, Rodrigues ALS. Ascorbic acid to manage psychiatric disorders. CNS Drugs. 2017 Jul;31(7):571-583. DOI: 10.1007/s40263-017-0446-8

118. Kaźmierczak-Barańska J, Boguszewska K, Adamus-Grabicka A, Karwowski BT. Two faces of vitamin C-antioxidative and pro-oxidative agent. Nutrients. 2020 May;12(5):E1501. DOI: 10.3390/nu12051501

119. Aschbacher K, O'Donovan A, Wolkowitz OM, Dhabhar FS, Su Y, Epel E. Good stress, bad stress and oxidative stress: insights from anticipatory cortisol reactivity. Psychoneuroendocrinology. 2013 Sep;38(9):1698-1708. DOI: 10.1016/j.psyneuen.2013.02.004

120. Moritz B, Schmitz AE, Rodrigues ALS, Dafre AL, Cunha MP. The role of vitamin C in stress-related disorders. J Nutr Biochem. 2020 Nov;85:108459. DOI: 10.1016/j.jnutbio.2020.108459

121. Cheraskin E, Ringsdorf WM, Medford FH. Daily vitamin C consumption and fatigability. J Am Geriatr Soc. 1976 Mar;24(3):136-137. DOI: 10.1111/j.1532-5415.1976.tb04284.x

122. Ding J, Zhang Y. Associations of dietary vitamin C and E intake with depression. A meta-analysis of observational studies. Front Nutr. 2022 Apr;9:857823. DOI: 10.3389/fnut.2022.857823

123. Gropper SS, Smith JL, Groff JL. Advanced nutrition and human metabolism. 5th ed. Belmont; Thomson Wadsworth; 2009. 86-90 p.

124. Cantó C, Auwerx J. Targeting sirtuin 1 to improve metabolism: all you need is NAD(+). Pharmacol Rev. 2012 Jan;64(1):166-187. DOI: 10.1124/pr.110.003905

125. Ou X, Lee MR, Huang X, Messina-Graham S, Broxmeyer HE. SIRT1 positively regulates autophagy and mitochondria function in embryonic stem cells under oxidative stress. Stem Cells. 2014 May;32(5):1183-1194. DOI: 10.1002/stem.1641

126. Libert S, Pointer K, Bell EL, Das A, Cohen DE, Asara JM, et al. SIRT1 activates MAO-A in the brain to mediate anxiety and exploratory drive. Cell. 2011 Dec;147(7):1459-1472. DOI: 10.1016/j.cell.2011.10.054

127. Sun X, Ming Q, Zhong X, Dong D, Li C, Xiong G, et al. The MAOA gene influences the neural response to psychosocial stress in the human brain. Front Behav Neurosci. 2020;14:65. DOI: 10.3389/fnbeh.2020.00065

128. Cerutti R, Pirinen E, Lamperti C, Marchet S, Sauve AA, Li W, et al. NAD(+)-dependent activation of Sirt1 corrects the phenotype in a mouse model of mitochondrial disease. Cell Metab. 2014 Jun;19(6):1042-1049. DOI: 10.1016/j.cmet.2014.04.001

129. Pan L, Jaroenporn S, Yamamoto T, Nagaoka K, Azumano I, Onda M, et al. Effects of pantothenic acid supplement on secretion of steroids by the adrenal cortex in female rats. Reprod Med Biol. 2012 Apr;11(2):101-104. DOI: 10.1007/s12522-011-0113-6

130. Jaroenporn S, Yamamoto T, Itabashi A, Nakamura K, Azumano I, Watanabe G, et al. Effects of pantothenic acid supplementation on adrenal steroid secretion from male rats. Biol Pharm Bull. 2008 Jun;31(6):1205-1208. DOI: 10.1248/bpb.31.1205

131. Chang TY, Li BL, Chang CCY, Urano Y. Acyl-coenzyme A:cholesterol acyltransferases. Am J Physiol Endocrinol Metab. 2009 Jul;297(1):E1-9. DOI: 10.1152/ajpendo.90926.2008

132. Edwards PA. Cholesterol synthesis. In: Lennarz WJ, Lane MD, editors. Encyclopedia of biological chemistry. Amsterdam: Elsevier Academic Press; 2004. p. 451-455.

133. Sanvictores T, Chauhan S. Vitamin B5 (pantothenic acid) [Internet]. Treasure Island: StatPearls; 2022 [cited 2022 Sep 1]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK563233/

134. Sato K. Why is vitamin B6 effective in alleviating the symptoms of autism. Med Hypotheses. 2018 Jun;115:103-106. DOI: 10.1016/j.mehy.2018.04.007

135. Cabib S, Puglisi-Allegra S. The mesoaccumbens dopamine in coping with stress. Neurosci Biobehav Rev. 2012 Jan;36(1):79-89. DOI: 10.1016/j.neubiorev.2011.04.012

136. Berger M, Gray JA, Roth BL. The expanded biology of serotonin. Annu Rev Med. 2009;60:355-366. DOI: 10.1146/annurev.med.60.042307.110802

137. Ruhé HG, Mason NS, Schene AH. Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies. Mol Psychiatry. 2007 Apr;12(4):331-359. DOI: 10.1038/sj.mp.4001949

138. Sarawagi A, Soni ND, Patel AB. Glutamate and GABA homeostasis and neurometabolism in major depressive disorder. Front Psychiatry. 2021;12:637863. DOI: 10.3389/fpsyt.2021.637863

139. Langendorf CG, Tuck KL, Key TLG, Fenalti G, Pike RN, Rosado CJ, et al. Structural characterization of the mechanism through which human glutamic acid decarboxylase auto-activates. Biosci Rep. 2013 Jan;33(1):137-144. DOI: 10.1042/BSR20120111

140. Krystal JH, Sanacora G, Blumberg H, Anand A, Charney DS, Marek G, et al. Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments. Mol Psychiatry. 2002;7 Suppl 1:S71-80. DOI: 10.1038/sj.mp.4001021

141. Wu Y, Zhang L, Li S, Zhang D. Associations of dietary vitamin B1, vitamin B2, vitamin B6, and vitamin B12 with the risk of depression: a systematic review and meta-analysis. Nutr Rev. 2022 Feb;80(3):351-366. DOI: 10.1093/nutrit/nuab014

142. Kafeshani M, Feizi A, Esmaillzadeh A, Keshteli AH, Afshar H, Roohafza H, et al. Higher vitamin B6 intake is associated with lower depression and anxiety risk in women but not in men: a large cross-sectional study. Int J Vitam Nutr Res. 2020 Oct;90(5-6):484-492. DOI: 10.1024/0300-9831/a000589

143. Hvas AM, Juul S, Bech P, Nexø E. Vitamin B6 level is associated with symptoms of depression. Psychother Psychosom. 2004 Nov-Dec;73(6):340-343. DOI: 10.1159/000080386

144. Gougeon L, Payette H, Morais JA, Gaudreau P, Shatenstein B, Gray-Donald K. Intakes of folate, vitamin B6 and B12 and risk of depression in community-dwelling older adults: the Quebec Longitudinal Study on Nutrition and Aging. Eur J Clin Nutr. 2016 Mar;70(3):380-385. DOI: 10.1038/ejcn.2015.202

145. Skarupski KA, Tangney C, Li H, Ouyang B, Evans DA, Morris MC. Longitudinal association of vitamin B-6, folate, and vitamin B-12 with depressive symptoms among older adults over time. Am J Clin Nutr. 2010 Aug;92(2):330-335. DOI: 10.3945/ajcn.2010.29413

146. Mahdavifar B, Hosseinzadeh M, Salehi-Abargouei A, Mirzaei M, Vafa M. Dietary intake of B vitamins and their association with depression, anxiety, and stress symptoms: a cross-sectional, population-based survey. J Affect Disord. 2021 Jun;288:92-98. DOI: 10.1016/j.jad.2021.03.055

147. Niki E. Evidence for beneficial effects of vitamin E. Korean J Intern Med. 2015 Sep;30(5):571-579. DOI: 10.3904/kjim.2015.30.5.571

148. Aleksandrovskiĭ IuA, Poiurovskiĭ MV, Neznamov GG, Seredeniia SB, Krasova EA. [Lipid peroxidation in emotional stress and neurotic disorders]. Zh Nevropatol Psikhiatr Im S S Korsakova. 1988;88(11):95-101.

149. Matsumoto K, Yobimoto K, Huong NT, Abdel-Fattah M, Van Hien T, Watanabe H. Psychological stress-induced enhancement of brain lipid peroxidation via nitric oxide systems and its modulation by anxiolytic and anxiogenic drugs in mice. Brain Res. 1999 Aug;839(1):74-84. DOI: 10.1016/s0006-8993(99)01715-1

150. Owen AJ, Batterham MJ, Probst YC, Grenyer BFS, Tapsell LC. Low plasma vitamin E levels in major depression: diet or disease. Eur J Clin Nutr. 2005 Feb;59(2):304-306. DOI: 10.1038/sj.ejcn.1602072

151. Manosso LM, Camargo A, Dafre AL, Rodrigues ALS. Vitamin E for the management of major depressive disorder: possible role of the anti-inflammatory and antioxidant systems. Nutr Neurosci. 2022 Jun;25(6):1310-1324. DOI: 10.1080/1028415X.2020.1853417

152. Brandão-Neto J, De Mendonça BB, Shuhama T, Marchini JS, Pimenta WP, Tornero MT. Zinc acutely and temporarily inhibits adrenal cortisol secretion in humans. A preliminary report. Biol Trace Elem Res. 1990 Jan;24(1):83-89. DOI: 10.1007/BF02789143

153. Takeda A, Tamano H, Nishio R, Murakami T. Behavioral abnormality induced by enhanced hypothalamo-pituitary-adrenocortical axis activity under dietary zinc deficiency and its usefulness as a model. Int J Mol Sci. 2016 Jul;17(7):E1149. DOI: 10.3390/ijms17071149

154. Di S, Maxson MM, Franco A, Tasker JG. Glucocorticoids regulate glutamate and GABA synapse-specific retrograde transmission via divergent nongenomic signaling pathways. J Neurosci. 2009 Jan;29(2):393-401. DOI: 10.1523/JNEUROSCI.4546-08.2009

155. Rajmohan V, Mohandas E. The limbic system. Indian J Psychiatry. 2007 Apr;49(2):132-139. DOI: 10.4103/0019-5545.33264

156. Cunha C, Brambilla R, Thomas KL. A simple role for BDNF in learning and memory. Front Mol Neurosci. 2010;3:1. DOI: 10.3389/neuro.02.001.2010

157. Bathina S, Das UN. Brain-derived neurotrophic factor and its clinical implications. Arch Med Sci. 2015 Dec;11(6):1164-1178. DOI: 10.5114/aoms.2015.56342

158. Shinoda Y, Ahmed S, Ramachandran B, Bharat V, Brockelt D, Altas B, et al. BDNF enhances spontaneous and activity-dependent neurotransmitter release at excitatory terminals but not at inhibitory terminals in hippocampal neurons. Front Synaptic Neurosci. 2014;6:27. DOI: 10.3389/fnsyn.2014.00027

159. Tyler WJ, Perrett SP, Pozzo-Miller LD. The role of neurotrophins in neurotransmitter release. Neuroscientist. 2002 Dec;8(6):524-531. DOI: 10.1177/1073858402238511

160. Młyniec K. Zinc in the glutamatergic theory of depression. Curr Neuropharmacol. 2015;13(4):505-513. DOI: 10.2174/1570159x13666150115220617

161. Ebadi M, Itoh M, Bifano J, Wendt K, Earle A. The role of Zn2+ in pyridoxal phosphate mediated regulation of glutamic acid decarboxylase in brain. Int J Biochem. 1981;13(10):1107-1112. DOI: 10.1016/0020-711x(81)90174-9

162. Vashum KP, McEvoy M, Milton AH, McElduff P, Hure A, Byles J, et al. Dietary zinc is associated with a lower incidence of depression: findings from two Australian cohorts. J Affect Disord. 2014 Sep;166:249-257. DOI: 10.1016/j.jad.2014.05.016

163. Yary T, Aazami S. Dietary intake of zinc was inversely associated with depression. Biol Trace Elem Res. 2012 Mar;145(3):286-290. DOI: 10.1007/s12011-011-9202-y

164. Yosaee S, Clark CCT, Keshtkaran Z, Ashourpour M, Keshani P, Soltani S. Zinc in depression: from development to treatment: a comparative/ dose response meta-analysis of observational studies and randomized controlled trials. Gen Hosp Psychiatry. 2022 Jan-Feb;74:110-117. DOI: 10.1016/j.genhosppsych.2020.08.001

165. Siwek M, Dudek D, Schlegel-Zawadzka M, Morawska A, Piekoszewski W, Opoka W, et al. Serum zinc level in depressed patients during zinc supplementation of imipramine treatment. J Affect Disord. 2010 Nov;126(3):447-452. DOI: 10.1016/j.jad.2010.04.024

166. Marin H, Menza MA. Specific treatment of residual fatigue in depressed patients. Psychiatry (Edgmont). 2004 Sep;1(2):12-18.

167. Daniels J, Brigden A, Kacorova A. Anxiety and depression in chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): examining the incidence of health anxiety in CFS/ME. Psychol Psychother. 2017 Sep;90(3):502-509. DOI: 10.1111/papt.12118

168. Wolfram M, Bellingrath S, Feuerhahn N, Kudielka BM. Emotional exhaustion and overcommitment to work are differentially associated with hypothalamus-pituitary-adrenal (HPA) axis responses to a low-dose ACTH1-24 (Synacthen) and dexamethasone-CRH test in healthy school teachers. Stress. 2013 Jan;16(1):54-64. DOI: 10.3109/10253890.2012.683465

169. Trivedi R, Sharma K. Hydroalcoholic extract of Glycyrrhiza glabra Linn. attentuates chronic fatigue stress induced behavioral alterations in mice. Int J Pharm Biol Sci Arch. 2011;2(3):996-1001.

170. Sadek MT, El-Abd SS, Ibrahim MAA. Effect of chronic unpredictable mild stress on adrenal cortex of adult rat and the possible protective role of licorice extract: a histological and immunohistochemical study. Egypt J Histol. 2021 Dec;44(4):887-901. DOI: 10.21608/EJH.2020.45532.1369

171. McEwen BS. Neurobiological and systemic effects of chronic stress. Chronic Stress (Thousand Oaks). 2017 Jan-Dec;1. DOI: 10.1177/2470547017692328

172. Cooley K, Szczurko O, Perri D, Mills EJ, Bernhardt B, Zhou Q, et al. Naturopathic care for anxiety: a randomized controlled trial ISRCTN78958974. PLoS One. 2009 Aug;4(8):e6628. DOI: 10.1371/journal.pone.0006628

173. Nevanperä NJ, Hopsu L, Kuosma E, Ukkola O, Uitti J, Laitinen JH. Occupational burnout, eating behavior, and weight among working women. Am J Clin Nutr. 2012 Apr;95(4):934-943. DOI: 10.3945/ajcn.111.014191

174. Kyrou I, Tsigos C. Chronic stress, visceral obesity and gonadal dysfunction. Hormones (Athens). 2008 Oct-Dec;7(4):287-293. DOI: 10.14310/horm.2002.1209

175. Choudhary D, Bhattacharyya S, Joshi K. Body weight management in adults under chronic stress through treatment with ashwagandha root extract: a double-blind, randomized, placebo-controlled trial. J Evid Based Complementary Altern Med. 2017 Jan;22(1):96-106. DOI: 10.1177/2156587216641830

176. Field DT, Cracknell RO, Eastwood JR, Scarfe P, Williams CM, Zheng Y, et al. High-dose vitamin B6 supplementation reduces anxiety and strengthens visual surround suppression. Hum Psychopharmacol. 2022 Jul:e2852. DOI: 10.1002/hup.2852

177. Kalueff AV, Nutt DJ. Role of GABA in anxiety and depression. Depress Anxiety. 2007;24(7):495-517. DOI: 10.1002/da.20262

178. Australian Bureau of Statistics. Mental health [Internet]. Canberra: Australian Bureau of Statistics; 2018 [cited 2022 May 16]. Available from: https://www.abs.gov.au/statistics/health/mental-health/mental-health/latest-release

179. Fifer S, Puig A, Sequeira V, Acar M, Ng CH, Blanchard M, et al. Understanding treatment preferences of Australian patients living with treatment-resistant depression. Patient Prefer Adherence. 2021 Jul;15:1621-1637. DOI: 10.2147/PPA.S311699

180. Jaffe DH, Rive B, Denee TR. The humanistic and economic burden of treatment-resistant depression in Europe: a cross-sectional study. BMC Psychiatry. 2019 Aug;19(1):247. DOI: 10.1186/s12888-019-2222-4

181. Souery D, Papakostas GI, Trivedi MH. Treatment-resistant depression. J Clin Psychiatry. 2006;67 Suppl 6:16-22.

182. Aburawi SM, Ghambirlou FA, Attumi AA, Altubuly RA, Kara AA. Effect of ascorbic acid on mental depression drug therapy: clinical study. J Psychol Psychother. 2014;4(1):1000131. DOI: 10.4172/2161-0487.1000131

183. Lin S, Huang L, Luo ZC, Li X, Jin SY, Du ZJ, et al. The ATP level in the medial prefrontal cortex regulates depressive-like behavior via the medial prefrontal cortex-lateral habenula pathway. Biol Psychiatry. 2022 Aug;92(3):179-192. DOI: 10.1016/j.biopsych.2022.02.014

184. Cao X, Li LP, Wang Q, Wu Q, Hu HH, Zhang M, et al. Astrocyte-derived ATP modulates depressive-like behaviors. Nat Med. 2013 Jun;19(6):773-777. DOI: 10.1038/nm.3162

185. Gardner A, Johansson A, Wibom R, Nennesmo I, Von Döbeln U, Hagenfeldt L, et al. Alterations of mitochondrial function and correlations with personality traits in selected major depressive disorder patients. J Affect Disord. 2003 Sep;76(1-3):55-68. DOI: 10.1016/s0165-0327(02)00067-8

186. Kang H, Oka S, Lee DY, Park J, Aponte AM, Jung YS, et al. Sirt1 carboxyl-domain is an ATP-repressible domain that is transferrable to other proteins. Nat Commun. 2017 May;8:15560. DOI: 10.1038/ncomms15560

187. Liu Z, Li C, Fan X, Kuang Y, Zhang X, Chen L, et al. Nicotinamide, a vitamin B3 ameliorates depressive behaviors independent of SIRT1 activity in mice. Mol Brain. 2020 Nov;13(1):162. DOI: 10.1186/s13041-020-00703-4

188. Bourre JM. Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. Part 1: micronutrients. J Nutr Health Aging. 2006 Sep-Oct;10(5):377-385.

189. Lobato KR, Cardoso CC, Binfaré RW, Budni J, Wagner CLR, Brocardo PS, et al. Alpha-tocopherol administration produces an antidepressant-like effect in predictive animal models of depression. Behav Brain Res. 2010 Jun;209(2):249-259. DOI: 10.1016/j.bbr.2010.02.002

190. Manosso LM, Neis VB, Moretti M, Daufenbach JF, Freitas AE, Colla AR, et al. Antidepressant-like effect of α-tocopherol in a mouse model of depressive-like behavior induced by TNF-α. Prog Neuropsychopharmacol Biol Psychiatry. 2013 Oct;46:48-57. DOI: 10.1016/j.pnpbp.2013.06.012

191. Herbet M, Izdebska M, Piątkowska-Chmiel I, Gawrońska-Grzywacz M, Natorska-Chomicka D, Pawłowski K, et al. α-tocopherol ameliorates redox equilibrium and reduces inflammatory response caused by chronic variable stress. Biomed Res Int. 2018 Nov;2018:7210783. DOI: 10.1155/2018/7210783

192. Siwek M, Dudek D, Paul IA, Sowa-Kućma M, Zieba A, Popik P, et al. Zinc supplementation augments efficacy of imipramine in treatment resistant patients: a double blind, placebo-controlled study. J Affect Disord. 2009 Nov;118(1-3):187-195. DOI: 10.1016/j.jad.2009.02.014

193. Ranjbar E, Shams J, Sabetkasaei M, M-Shirazi M, Rashidkhani B, Mostafavi A, et al. Effects of zinc supplementation on efficacy of antidepressant therapy, inflammatory cytokines, and brain-derived neurotrophic factor in patients with major depression. Nutr Neurosci. 2014 Feb;17(2):65-71. DOI: 10.1179/1476830513Y.0000000066

194. Nowak G, Siwek M, Dudek D, Zieba A, Pilc A. Effect of zinc supplementation on antidepressant therapy in unipolar depression: a preliminary placebo-controlled study. Pol J Pharmacol. 2003 Nov-Dec;55(6):1143-1147.

195. Manosso LM, Moretti M, Colla AR, Ribeiro CM, Dal-Cim T, Tasca CI, et al. Involvement of glutamatergic neurotransmission in the antidepressant-like effect of zinc in the chronic unpredictable stress model of depression. J Neural Transm (Vienna). 2016 Mar;123(3):339-352. DOI: 10.1007/s00702-015-1504-3

196. Omar NN, Tash RF. Fluoxetine coupled with zinc in a chronic mild stress model of depression: providing a reservoir for optimum zinc signaling and neuronal remodeling. Pharmacol Biochem Behav. 2017 Sep;160:30-38. DOI: 10.1016/j.pbb.2017.08.003

197. Augustine Egwu O, Dimkpa U, Ogbonnaya Orji J, Ogbannaya Njoku C, Ogbonnia Eni E, Besong E. Medical students - self-assessed confidence level before a major physiology examination: affective factors in a Nigerian medical school. Acta Inform Med. 2011 Sep;19(3):153-157. DOI: 10.5455/aim.2011.19.153-157

198. Mazzone L, Ducci F, Scoto MC, Passaniti E, D'Arrigo VG, Vitiello B. The role of anxiety symptoms in school performance in a community sample of children and adolescents. BMC Public Health. 2007 Dec;7:347. DOI: 10.1186/1471-2458-7-347

199. Al-Fahham AA. Effect of low dose vitamin C on public speaking stress during group presentation. J Phys Conf Ser. 2019 Sep;1294(6):062054. DOI: 10.1088/1742-6596/1294/6/062054

200. De Oliveira IJ, De Souza VV, Motta V, Da-Silva SL. Effects of oral vitamin C supplementation on anxiety in students: a double-blind, randomized, placebo-controlled trial. Pak J Biol Sci. 2015 Jan;18(1):11-18. DOI: 10.3923/pjbs.2015.11.18